OncoLink Cancer Treatment and Resources

Pilocytic astrocytoma

Hui-Kuo G. Shu, MD, PhD
Last Modified: September 29, 2002

Question

Dear OncoLink "Ask The Experts,"

My 20-month-old son was recently diagnosed with a pilocytic astrocytoma attached to his brain stem. The tumor was explained to me as being mildly malignant with a possibility of becoming more aggressive. During his surgery 2/3 of the tumor was removed. My question is; of the remaining tumor, are there any studies that show the percentage of this astrocytoma becoming more aggressive (more malignant)?

 

Answer

Hui-Kuo G. Shu, MD, PhD, Assistant Professor in the Department of Radiation Oncology at the University of Pennsylvania, responds:

Your son has a pilocytic astrocytoma that had a significant portion resected (surgically removed). Pilocytic astrocytomas are considered the lowest grade astrocytomas (least aggressive). They tend to be well-circumscribed and, depending on the location, can often be completely resected (which is generally considered to be curative). However, some locations, such as in the brainstem, are more difficult to resect completely because of potential morbidity associated with a highly aggressive surgical approach. In this situation where a subtotal resection is performed, a significant risk of tumor progression exists. If there were a recurrence, the great majority of these would continue to be pilocytic at recurrence. However, as your son's physicians have correctly informed you, the possibility exists for malignant transformation at progression. The probability of this occurring is very low with an estimated incidence of 0.9% based on a study of 107 patients with cerebellar pilocytic astrocytoma by a group at the Mayo Clinic (Tomlinson et al., J Child Neurol 9:301-10, 1994). Therefore, while malignant transformation can happen, it is very rare.

OncoLink I wish u knew...

Dr. O'Dwyer discusses pancreatic cancer, family history, screening and future research. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS